These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37843108)

  • 1. An Orally-Administered Nanotherapeutics with Carbon Monoxide Supplying for Inflammatory Bowel Disease Therapy by Scavenging Oxidative Stress and Restoring Gut Immune Homeostasis.
    Zhang X; Yuan Z; Wu J; He Y; Lu G; Zhang D; Zhao Y; Wu R; Lv Y; Cai K; He S
    ACS Nano; 2023 Nov; 17(21):21116-21133. PubMed ID: 37843108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally Administrated Inflamed Colon-Targeted Nanotherapeutics for Inflammatory Bowel Disease Treatment by Oxidative Stress Level Modulation in Colitis.
    Min DK; Kim YE; Kim MK; Choi SW; Park N; Kim J
    ACS Nano; 2023 Dec; 17(23):24404-24416. PubMed ID: 38039189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycatechol-Derived Mesoporous Polydopamine Nanoparticles for Combined ROS Scavenging and Gene Interference Therapy in Inflammatory Bowel Disease.
    Wang L; Wang Z; Pan Y; Chen S; Fan X; Li X; Chen G; Ma Y; Cai Y; Zhang J; Yang H; Xiao W; Yu M
    ACS Appl Mater Interfaces; 2022 May; 14(17):19975-19987. PubMed ID: 35442639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mesoporous polydopamine-derived nanomedicine for targeted and synergistic treatment of inflammatory bowel disease by pH-Responsive drug release and ROS scavenging.
    Guan H; Xu Z; Du G; Liu Q; Tan Q; Chen Y; Chen S; Wu J; Wang F; Zhang J; Sun L; Xiao W
    Mater Today Bio; 2023 Apr; 19():100610. PubMed ID: 37009068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A drug-free nanozyme for mitigating oxidative stress and inflammatory bowel disease.
    Zeng F; Shi Y; Wu C; Liang J; Zhong Q; Briley K; Xu B; Huang Y; Long M; Wang C; Chen J; Tang Y; Li X; Jiang M; Wang L; Xu Q; Yang L; Chen P; Duan S; Xie J; Li C; Wu Y
    J Nanobiotechnology; 2022 Mar; 20(1):107. PubMed ID: 35246140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aronia melanocarpa (Michx.) Elliott. attenuates dextran sulfate sodium-induced Inflammatory Bowel Disease via regulation of inflammation-related signaling pathways and modulation of the gut microbiota.
    Li Y; Nguepi Tsopmejio IS; Diao Z; Xiao H; Wang X; Jin Z; Song H
    J Ethnopharmacol; 2022 Jun; 292():115190. PubMed ID: 35306040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally Administered Silicon Hydrogen Nanomaterials as Target Therapy to Treat Intestinal Diseases.
    Wei K; Gong F; Wu J; Tang W; Liao F; Han Z; Pei Z; Lei H; Wang L; Shao M; Liu Z; Cheng L
    ACS Nano; 2023 Nov; 17(21):21539-21552. PubMed ID: 37843009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally administered titanium carbide nanosheets as anti-inflammatory therapy for colitis.
    Hou L; Gong F; Liu B; Yang X; Chen L; Li G; Gong Y; Liang C; Yang N; Shen X; Liu Z; Cheng L
    Theranostics; 2022; 12(8):3834-3846. PubMed ID: 35664066
    [No Abstract]   [Full Text] [Related]  

  • 9. ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease.
    Bao M; Wang K; Li J; Li Y; Zhu H; Lu M; Zhang Y; Fan Q; Han L; Wang K; Wang D; Gao Y; Peng B; Ming Z; Liu W
    Acta Biomater; 2023 Apr; 161():250-264. PubMed ID: 36863680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Nanotherapeutics of Andrographolide/Carbon Monoxide Donor for Synergistically Anti-inflammatory and Pro-resolving Treatment of Ulcerative Colitis.
    Zhou Y; Yang M; Yan X; Zhang L; Lu N; Ma Y; Zhang Y; Cui M; Zhang M; Zhang M
    ACS Appl Mater Interfaces; 2023 Aug; 15(30):36061-36075. PubMed ID: 37463480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyphenolic Nanoparticle-Modified Probiotics for Microenvironment Remodeling and Targeted Therapy of Inflammatory Bowel Disease.
    Hu Q; Li J; Wang T; Xu X; Duan Y; Jin Y
    ACS Nano; 2024 May; 18(20):12917-12932. PubMed ID: 38720520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair.
    Lei F; Zeng F; Yu X; Deng Y; Zhang Z; Xu M; Ding N; Tian J; Li C
    J Nanobiotechnology; 2023 Aug; 21(1):275. PubMed ID: 37596598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methane Alleviates Inflammation and Apoptosis of Dextran Sulfate Sodium-Induced Inflammatory Bowel Diseases by Inhibiting Toll-Like Receptor 4 (TLR4)/Myeloid Differentiation Factor 88 (MyD88)/Nuclear Translocation of Nuclear Factor-κB (NF-κB) and Endoplasmic Reticulum Stress Pathways in Mice.
    Shen N; Wang Z; Wang C; Zhang J; Liu C
    Med Sci Monit; 2020 Jun; 26():e922248. PubMed ID: 32500859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogen-rich water protects against inflammatory bowel disease in mice by inhibiting endoplasmic reticulum stress and promoting heme oxygenase-1 expression.
    Shen NY; Bi JB; Zhang JY; Zhang SM; Gu JX; Qu K; Liu C
    World J Gastroenterol; 2017 Feb; 23(8):1375-1386. PubMed ID: 28293084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal anesthesia alleviates dextran sodium sulfate-induced colitis by modulating the gut microbiota.
    Hong Y; Zhao J; Chen YR; Huang ZH; Hou LD; Shen B; Xin Y
    World J Gastroenterol; 2022 Mar; 28(12):1239-1256. PubMed ID: 35431512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the PPARγ/NF-κB pathway by A-MPDA@Fe
    Mo D; Cui W; Chen L; Meng J; Sun Y; Cai K; Zhang J; Zhang J; Wang K; Luo X
    J Mater Chem B; 2024 Jun; 12(23):5722-5733. PubMed ID: 38764419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulating the Imbalance of Gut Microbiota by
    Xu M; Xue H; Qiao G; Liao M; Kong L; Zhang Q; Lin L; Yang L; Zheng G
    Am J Chin Med; 2022; 50(2):553-568. PubMed ID: 35114911
    [No Abstract]   [Full Text] [Related]  

  • 18. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite effect of oxidative stress on inducible nitric oxide synthase and haem oxygenase-1 expression in intestinal inflammation: anti-inflammatory effect of carbon monoxide.
    Dijkstra G; Blokzijl H; Bok L; Homan M; van Goor H; Faber KN; Jansen PL; Moshage H
    J Pathol; 2004 Nov; 204(3):296-303. PubMed ID: 15476266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrathin Hafnium Disulfide Atomic Crystals with ROS-Scavenging and Colon-Targeting Capabilities for Inflammatory Bowel Disease Treatment.
    Li R; Fan Y; Liu L; Ma H; Gong D; Miao Z; Wang H; Zha Z
    ACS Nano; 2022 Sep; 16(9):15026-15041. PubMed ID: 36037406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.